New molecules and treatment modulation in advanced prostatic cancer
Mahler, C.; Verhelst, J.; Denis, L.
Acta Urologica Belgica 64(2): 95-98
1996
ISSN/ISBN: 0001-7183 PMID: 8701825 Document Number: 464691
Document emailed within 1 workday
Related Documents
Fosså, S.D.; Miller, A. 1975: Treatment of advanced prostatic cancer Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 95(13): 811-814Murray, R.; Pitt, P. 1987: Aminoglutethimide in the treatment of advanced prostatic cancer Progress in Clinical and Biological Research 243a: 275-282
Grem, J.L. 2001: Biochemical modulation of 5-FU in systemic treatment of advanced colorectal cancer Oncology 15(1 Suppl 2: 13-19
Jönsson, G. 1971: Continued experiences with Estracyt in the treatment of advanced prostatic cancer Nordisk Medicin 85(6): 186-187
Sarfaty, G.A.; Alder, S.J.; McLean, R.G. 1984: A pilot study of flutamide. a new agent in the treatment of advanced prostatic cancer Medical Journal of Australia 140(4): 219-221
Porena, M.; Rosi, P.; Valli, P.P.; Cesaroni, S.; Mearini, E.; Marzi, M. 1994: Locally advanced prostatic cancer and systemic involvement Archivio Italiano di Urologia Andrologia: Organo Ufficiale di Societa Italiana di Ecografia Urologica e Nefrologica 66(4 Suppl): 179-181
Pummer, K. 1991: Epirubicin plus flutamide and orchidectomy in previously untreated advanced prostatic cancer Seminars in Oncology 18(5 Suppl 6: 26-28
Okumura, S.; Hasegawa, J.; Ohhara, M.; Kawamura, N.; Abe, H.; Yui, Y.; Kanamori, S.; Yoshida, K.; Nishimura, T.; Tomita, M. 1984: Treatment of advanced prostatic carcinoma with cis-diamminedichloroplatinum Hinyokika Kiyo. Acta Urologica Japonica 30(12): 1801-1807
Vachalovský, V.; Vomácka, V. 1988: Orimeten in the treatment of advanced prostatic carcinoma Rozhledy V Chirurgii: Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 67(10): 666-670
Lohse, R.; Schubert, J. 1972: Treatment of advanced metastasizing prostatic carcinoma Das Deutsche Gesundheitswesen 27(26): 1238-1241
Rafla, S.; Johnson, R. 1974: The treatment of advanced prostatic carcinoma with medroxyprogesterone Current Therapeutic Research 16(4): 261-267
Nagel, R. 1980: Practical limitations of a controlled multicenter therapeutic study with the example of advanced inoperable prostatic cancer Verhandlungen der Deutschen Gesellschaft für Innere Medizin 86: 1304-1316
Matzkin, H.; Greenstein, A.; Kaver, I.; Braf, Z. 1989: Use of gonadotropin-releasing hormone analogue in advanced prostatic cancer: 3 years clinical experience Israel Journal of Medical Sciences 25(7): 388-392
Tsavaris, N.; Zinelis, A.; Karvounis, N.; Beldecos, D.; Mylonacis, N.; Zamanis, N.; Bacoyannis, C.; Valilis, P.; Antonopoulos, A.; Kosmidis, P. 1990: Multimodal biochemical modulation of 5-fluorouracil activity in advanced colorectal cancer with allopurinol, folinic acid and dipyridamol Journal of Chemotherapy 2(2): 123-126
Korczak, D.; Golomb, J.; Siegel, Y.; Lindner, A. 1988: Treatment of advanced prostatic carcinoma with LHRH analogue Harefuah 115(5-6): 109-111
Sheth, A.R.; Garde, S.V.; Mehta, M.K.; Shah, M.G. 1992: Hormonal modulation of biosynthesis of prostatic specific antigen, prostate specific acid phosphatase and prostatic inhibin peptide Indian Journal of Experimental Biology 30(3): 157-161
Chime-Udeh, E. 1991: Leuprolide with flutamide for complete androgen ablation: therapeutic alternative for advanced prostatic cancer (stage D2) Connecticut Medicine 55(9): 526-528
Svábenský, M. 1986: Ketoconazole--new possibilities of treatment in advanced stages of prostatic carcinoma Casopis Lekaru Ceskych 125(48): 1488-1489
Wechsel, H.W.; Zerbib, M.; Pagano, F.; Coptcoat, M.J. 1996: Randomized open labelled comparative study of the efficacy, safety and tolerability of leuprorelin acetate 1M and 3M depot in patients with advanced prostatic cancer European Urology 30(Suppl): 7
Hao, X.K. 1993: Radioimmunodetection of prostatic cancer: in vivo 131I-gamma-seminoprotein for diagnosis of prostatic cancer by nuclear imaging Zhonghua Yi Xue Za Zhi 73(11): 655-657; 700